Schott Pharma

File:Abfüllautomat 1932 SCHOTT.jpg

File:Druckschrift Fiolenkörper 1923 SCHOTT.jpg

In 1887, Otto Schott developed borosilicate glass, a form of glassware used to reagent bottles and flasks. From 1911, Schott manufactured borosilicate glass tubing for the production of pharmaceutical ampoules and vials.{{cite web | url = https://www.glaskeramik.org/impfstoff-ampullen-rohrglas-fuer-lebensretter/ | title = Impfstoff-Ampullen – Rohrglas für Lebensretter - VBG Spezial |author= | date = 2021-07-04 | website = glaskeramik.org | publisher = VBG | access-date = 2024-02-28}}

Schott Pharma was established as a standalone company in 2022 under the name Schott Pharma AG & Co. KGaA{{Cite web |last=Dunleavy |first=Kevin |date=2023-09-06 |title=After one year as standalone business, glassmaker Schott Pharma sets course for IPO |url=https://www.fiercepharma.com/manufacturing/glassmaker-schott-pharma-set-go-public-year |access-date=2024-06-24 |website=Fierce Pharma}} through an equity carve-out (or spin-off) from Schott AG, a manufacturer of specialty glass and glass-ceramics.{{cite web | url = https://www.fiercepharma.com/manufacturing/schotts-pharma-business-strikes-out-its-own-will-ipo-follow | title = Glass maker Schott's pharma business sets out on its own. Will an IPO follow? | last = Kansteiner | first = Fraiser | date = 2022-01-08 | publisher = Fierce Pharma | access-date = 2024-02-28}}{{Cite web |last=Landsteiner |first=Fraiser |date=2022-08-01 |title=Glass maker Schott's pharma business sets out on its own. Will an IPO follow? |url=https://www.fiercepharma.com/manufacturing/schotts-pharma-business-strikes-out-its-own-will-ipo-follow |access-date=2024-06-24 |website=Fierce Pharma}} In the same year, the company announced their plans to present an IPO, but this was reportedly postponed to 2023 due to the Russian invasion of Ukraine.

In June 2023, Schott Pharma announced plans to hold the IPO in September 2023.{{Cite journal |last=Wilkes |first=William |last2=Gopinath |first2=Swetha |date=2023-06-22 |title=Schott to Hold IPO of Medical Glassware Unit in September: Bloomberg.com |url= |journal=Bloomberg.com |pages=N.PAG–N.PAG}} This plan was enacted in September, with Schott Pharma going public on the Frankfurt Stock Exchange.{{Cite journal |date=2023-10-16 |title=Schott Pharma trades up following biggest German IPO since Porsche: Global Capital |url= |journal=Global Capital |pages=N.PAG–N.PAG}} The IPO was initially priced at 27€ per share,{{Cite web |last=Gopinath |first=Swetha |date=2023-09-28 |title=Germany's Schott Raises €813 Million in IPO of Medical-Glass Arm |url=https://www.bloomberg.com/news/articles/2023-09-27/germany-s-schott-raises-813-million-in-ipo-of-medical-glass-arm?embedded-checkout=true |access-date=2024-06-24 |website=www.bloomberg.com}}{{Cite web |last=gsp |date=2023-09-29 |title=Schott Pharma geht mit Freshfields an die Frankfurter Börse |trans-title=Schott Pharma goes to the Frankfurt Stock Exchange with Freshfields |url=https://extrajournal.net/2023/09/29/schott-pharma-geht-mit-freshfields-an-die-frankfurter-boerse/ |access-date=2024-06-24 |website=Extrajournal.Net |language=de-DE}} and a potential valuation of up to 4.1 billion euros,{{Cite web |date=2023-09-27 |title=Schott Pharma prices IPO at 27 euros per share |url=https://www.reuters.com/markets/deals/schott-pharma-prices-ipo-27-euros-per-share-2023-09-27/ |access-date=2024-06-24 |website=Reuters}} but increased the share price to 30€ the following day.{{Cite web |date=2023-09-28 |title=SCHOTT Pharma feiert erfolgreiches Börsendebüt: Erstkurs über Ausgabepreis |trans-title=SCHOTT Pharma celebrates successful stock market debut: First price on issue price |url=https://www.finanzen.net/nachricht/aktien/boersengang-in-frankfurt-schott-pharma-feiert-erfolgreiches-boersendebuet-erstkurs-ueber-ausgabepreis-12864623 |access-date=2024-06-24 |website=Finanzen Net |language=German}} The IPO was the largest of the year in Germany.{{cite web | url = https://www.reuters.com/markets/deals/schott-pharma-debuts-frankfurt-stock-exchange-2023-09-28/ | title = Schott Pharma shares jump 16% in Frankfurt trading debut | last1 = Farr | first1 = Emma-Victoria | last2 = Mayo Cerqueiro | first2 = Pablo | date = 2023-09-28 | website = reuters.com | publisher = Reuters | access-date = 2024-02-28}}{{cite web | url = https://www.tagesschau.de/wirtschaft/finanzen/schott-pharma-ipo-boersengang-aktie-100.html | title = Schott Pharma startet erfolgreich an der Börse | author= | date = 2023-09-28 | website = tagesschau.de | access-date = 2024-02-28}} In December 2023, Schott Pharma was included in the SDAX.{{cite web | url = https://www.capital.de/geld-versicherungen/schott-pharma-aktie--small-cap-mit-potenzial-und-bald-im-sdax-34282858.html | title = Profitabler Small Cap: Zulieferer Schott Pharma bald im SDax | last = Ingerl | first = Christian | date = 2023-12-13 | publisher = Capital | access-date = 2024-02-28}} In September 2024, Schott Pharma was promoted to the MDAX.{{Cite web |last=Ruhkamp|first=Christoph |date=2024-10-04 |title=Finanzchefin bringt Schott Pharma in den MDax |trans-title=Chief Financial Officer brings Schott Pharma into the MDax |url=https://www.boersen-zeitung.de/personen/finanzchefin-bringt-schott-pharma-in-den-mdax |access-date=2024-11-04 |website=boersen-zeitung.de |language=de}}

{{Expand section|date=June 2024}}

The company is headquartered in Mainz and operates in 16 locations across 14 countries.{{cite web | url = https://www.finanzen.net/nachricht/aktien/zwischenfazit-groesster-boersengang-in-2023-so-hat-sich-die-schott-pharma-aktie-seit-ihrem-ipo-entwickelt-und-so-koennte-es-in-2024-nun-weitergehen-13173248 | title = Größter Börsengang in 2023: So hat sich die SCHOTT Pharma-Aktie seit ihrem IPO entwickelt - und so könnte es in 2024 nun weitergehen | author= | date = 2024-01-24 | publisher = finanzen.net | access-date = 2024-02-28}}

• Müllhein, Germany (Müllheim Production and Technology Centre){{Cite web |last=Zeitung |first=Badische |date=2022-12-02 |title=SCHOTT Pharma: Ein globales Kompetenzzentrum in Müllheim |url=https://www.badische-zeitung.de/schott-pharma-ein-globales-kompetenzzentrum-in-muellheim |access-date=2024-06-24 |website=Badische Zeitung |language=de}}{{Cite web |last=Schlegel |first=Marion |date=2023-12-19 |title=SDAX-Neuling Schott Pharma gibt ordentlich Gas: Zahlen kommen gut an |url=https://www.deraktionaer.de/artikel/aktien/sdax-neuling-schott-pharma-gibt-ordentlich-gas-zahlen-kommen-gut-an-20346129.html |access-date=2024-06-24 |website=www.deraktionaer.de |language=de-de}}
• Hungary{{Cite web |date=2022-09-22 |title=SCHOTT Pharma baut Produktion in China und Ungarn aus – ZWP online – das Nachrichtenportal für die Dentalbranche |url=https://www.zwp-online.info/zwpnews/wirtschaft-und-recht/businessnews/schott-pharma-baut-produktion-in-china-und-ungarn-aus |access-date=2024-06-24 |website=www.zwp-online.info |language=de}}{{Cite web |date=2024-02-12 |title=SCHOTT: solides Ergebnis trotz konjunktureller Herausforderungen – ZWP online – das Nachrichtenportal für die Dentalbranche |trans-title=SCHOTT: solid result despite economic challenges |url=https://www.zwp-online.info/zwpnews/wirtschaft-und-recht/businessnews/solides-ergebnis-trotz-grosser-konjunktureller-herausforderungen |access-date=2024-06-24 |website=www.zwp-online.info |language=de}}{{Cite journal |last=Herpai |first=Gergely |date=2024-07-12 |title=Schott Pharma's HUF 28 bln Investment Boosts Hungarian Pharmaceutical Manufacturing: Budapest Business Journal |url= |journal=Budapest Business Journal |volume=32 |issue=14 |pages=8–8}}
• Switzerland
• Serbia{{Cite journal |date=July 2024 |title=Schott Pharma Begins Construction on Serbia Plant: American Ceramic Society Bulletin |url= |journal=American Ceramic Society Bulletin |volume=103 |issue=5 |pages=49–49}}

• Wilson, North Carolina{{Cite journal |last=Schott |date=2024-03-18 |title=SCHOTT Pharma to Expand in the U.S. with New Prefillable Syringe Manufacturing Facility in Wilson, North Carolina: Business Wire (English) |url=https://www.businesswire.com/news/home/20240318311726/en/ |journal=Business Wire (English)}}{{Cite journal |last=Anselmo |first=Joelle |date=2024-03-27 |title=Schott Pharma to build $371M syringe factory: Construction Dive |url= |journal=Construction Dive |pages=N.PAG–N.PAG}}
• Lebanon, Pennsylvania

• China

Schott Pharma develops and manufactures drug containment solutions and delivery systems for injectable drugs, which it supplies to companies in the biotechnology and pharmaceutical industries.

{{Citation | title = SCHOTT Pharma Annual Report 2022/2023 | publisher = SCHOTT Pharma | page = 14 | url = https://ir.schott-pharma.com/investor-relations/en/annual-report/ | access-date = 2024-02-28 }}

Its business is divided into two divisions:

• Drug Containment Solutions: pharmaceutical vials, cartridges, and glass ampoules{{Cite web |last=Kaiser |first=Lea |date=2023-10-24 |title=Next generation pharma glass: SCHOTT AG launches FIOLAX® Pro Glass tubing |url=https://www.businesswire.com/news/home/20231024340802/en/Next-generation-pharma-glass-SCHOTT-AG-launches-FIOLAX®-Pro-glass-tubing |access-date=2024-06-24 |website=BusinessWire}}
• Drug Delivery Systems: prefillable glass syringes and syringes made from Cyclic olefin copolymers (COC), suitable for deep-cold medications.{{cite web | url = https://www.nsmedicaldevices.com/news/schott-pharma-rolls-out-pre-filled-polymer-syringes/ | title = Schott Pharma rolls out pre-filled polymer syringes for deep-cold medication | author= | date = 2023-05-18 | publisher = NS Medical Devices | access-date = 2024-02-28}}

{{Gallery

|width=80 |height=120

|align=center

| File:Prefillable Glass Syringe by SCHOTT Pharma.jpg|Prefillable glass syringe

|File:Prefillable Polymer Syringe by SCHOTT Pharma.jpg|Prefillable polymer syringe

|File:Ampoule by SCHOTT Pharma.jpg|Ampoule

|File:Vial by SCHOTT Pharma.jpg|Vial

|File:Cartridge by SCHOTT Pharma.jpg|Cartridge

}}

Schott Pharma is a subsidiary of SCHOTT AG, which holds controlling shares (as of 2023: 77%). SCHOTT AG is owned by the Carl Zeiss Foundation.

Schott Pharma is listed on the Frankfurt Stock Exchange's MDAX.

{{Expand section|date=June 2024}}

In 2023 SCHOTT AG appointed a Supervisory Board for the subsidiary Schott Parma AG as follows:{{Cite web |last=Mills |first=Jess |date=2023-05-02 |title=Schott appoints Supervisory Board of Schott Pharma |url=https://www.glass-international.com/news/schott-appoints-supervisory-board-of-schott-pharma |access-date=2024-06-24 |website=Glass International |language=en}}{{Cite web |date=2023-05-02 |title=SCHOTT bestellt Aufsichtsrat der SCHOTT Pharma AG |trans-title=SCHOTT appoints Supervisory Board of SCHOTT Pharma AG |url=https://www.zwp-online.info/zwpnews/wirtschaft-und-recht/businessnews/schott-bestellt-aufsichtsrat-der-schott-pharma-ag |access-date=2024-06-24 |website=ZWP-online}}

• Peter Goldschmidt, (Chairman)
• Dr. Wolfgang Wienand (Chairman of the Executive Board of Siegfried Holding AG)
• Eva Kienle (CFO of KWS Saat SE & Co. KGaA)
• Ann-Kristin Erkens (Corporate Senior Vice President, Financial and Business Controlling at Henkel Adhesive Technologies)
• Christine Wening (employee stakeholder)
• Mario Just (employee stakeholder)

{{reflist}}

Category:Packaging companies

Category:Companies based in Mainz

Category:Medical technology companies of Germany

Category:Manufacturing companies established in 2022

Category:2022 establishments in Germany

Category:Companies listed on the Frankfurt Stock Exchange

Category:Companies in the MDAX